The total crypto market cap plunged by over $400 billion in just a couple of days. But what's behind it?The total crypto market cap plunged by over $400 billion in just a couple of days. But what's behind it?

What Crashed the Crypto Market on November 4 and Should You Worry?

2025/11/05 15:53
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The broader economic perspective shows few signs to worry and it certainly couldn’t predict what transpired in the cryptocurrency markets at the start of the current business week. Bitcoin traded at $111,000 on Sunday evening, ETH was above $3,900, XRP was at $2.60, and so on.

What followed, though, was a market-wide crash that pushed BTC down to just under $99,000 for the first time in almost five months. ETH turned negative YTD, dropping to $3,200. And these declines took place less than a week after the US Federal Reserve cut the interest rates, US and China made significant progress on the trade deal front, and the inflation numbers in the States were not as high as many feared.

So, why did crypto crash, and why did the market cap go down to $3.2 trillion, thus erasing $1 trillion since the October 6 all-time highs? Here’s the take from the Kobeissi Letter.

Why, Crypto, Why?

The analysts noted that the big answer to this question is “more technical than fundamental.” They believe that some of the key metrics for the industry, such as adoption levels, deregulation, and advancing technology, remain very high, which should be prompting investors to enter the market, not pushing them away.

However, they warned once again that leverage is at “unprecedented levels, which is amplifying moves in the market, such as the $20B liquidation seen on October 10.”

Consequently, the analysts warned that the short-term price picture points to “larger swings in both directions” due to the excessive leverage used by futures traders, but noted that the long-term thesis is “stronger than ever.”

One of Those Days

Crypto’s crash was not an isolated event, as most financial markets went down on Monday and Tuesday. Of course, their losses, even the 4.5% decline of the Japanese stock market, are nowhere near as damaging as crypto’s calamity, but that’s primarily because of the aforementioned leverage and the size of the actual market.

Consequently, the Kobeissi Letter determined once again that nothing had changed fundamentally and added that such corrections are experienced periodically during bull runs. The analyst concluded that “rate cuts have arrived, deregulation is here, earnings growth is running at 10%+ YoY, and the AI Revolution is accelerating,” and advised investors to “ignore the noise.”

The post What Crashed the Crypto Market on November 4 and Should You Worry? appeared first on CryptoPotato.

Market Opportunity
4 Logo
4 Price(4)
$0.008075
$0.008075$0.008075
-1.34%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09